πŸ‡ΊπŸ‡Έ FDA
Patent

US 9815824

Kappa opioid agonists and uses thereof

granted A61PA61P1/06A61P25/04

Quick answer

US patent 9815824 (Kappa opioid agonists and uses thereof) held by Nektar Therapeutics expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/06, A61P25/04